CVR: 43636472
Selskabets formål er at yde rådgivningstjenester inden for medicinalindustrien samt hermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 5.7 mio. | 1.1 mio. | 2.4 mio. | 1.8 mio. | 2 |
Compared to 11.298 companies in Virksomhedsrådgivning og anden ledelsesrådgivning
Comparison is based on industry median values
BioPactor ApS demonstrates a positive financial trajectory, with a notable increase in revenue from 2023 to 2024, rising to 5,673,940 DKK, and a profit growth to 1,118,435 DKK. The company's equity has also improved significantly, reaching 1,791,777 DKK, indicating a strengthening financial position. While the profit margins appear healthy, the lack of prior revenue data for 2023 raises questions about consistency and market presence. Overall, BioPactor is positioned favorably within the business consulting industry, but further clarity on its operational scale and market share would enhance understanding of its competitive standing.
AI-generated summary
Companies in the same industry and area
CVR 34011192
CVR 43075977
CVR 37324787
CVR 42253588
CVR 43695711
companydata.dk